Clever Leaves Holdings
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
The CIN framework assigns Clever Leaves Holdings a Neutral rating at 38/100, with conviction of 3 out of 5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 50 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.
Under the hood, the data points sit as follows: reported revenue growth of 5.4 percent year over year, an operating margin of -105.9 percent, gross margin of 37.6 percent, a jurisdictional posture reading of 55. Each of those figures ties back to a specific input in the pillar breakdown. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets Clever Leaves Holdings be lined up against Latin American operator peers on identical inputs, with refresh cadence tied directly to primary-source ingest.
Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 50. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.
- IR email
- info@cleverleaves.com
- Phone
- +1-201-565-3345
- SEC CIK
- 0001819615
- Website
- Company website
- Market cap
- $0.0M
- Enterprise value
- $-4.7M
- EV / EBITDA
- -0.07
- Revenue (TTM)
- $17.4M
- Gross profit (TTM)
- $6.6M
- EBITDA
- $-13.2M
- Operating margin
- -105.9%
- Profit margin
- -102.8%
- Rev growth YoY
- 5.4%
- Return on equity
- -61.3%
- Return on assets
- -23.4%
- EPS (TTM)
- $-2.11
- Wall St. target price
- $24.00
- Shares outstanding
- 1.8M
- Beta
- 1735.91
- Full-time employees
- 296
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Clever Leaves Holdings (CLVR)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Clever Leaves Holdings (CLVR), a cannabis-sector equity listed on NASDAQ. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, micro-cap. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CLVR are maintained by Cannabis Investor News and refreshed throughout the trading day.